ViewRay Valuation

VRAYDelisted Stock  USD 0.01  0.0001  1.11%   
ViewRay seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of ViewRay from inspecting the company fundamentals such as Return On Equity of -1.09, operating margin of (1.02) %, and Shares Outstanding of 183.4 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
0.01
Please note that ViewRay's price fluctuation is very steady at this time. Calculation of the real value of ViewRay is based on 3 months time horizon. Increasing ViewRay's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ViewRay is useful when determining the fair value of the ViewRay stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ViewRay. Since ViewRay is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ViewRay Stock. However, ViewRay's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0089 Real  0.008455 Hype  0.01
The real value of ViewRay Stock, also known as its intrinsic value, is the underlying worth of ViewRay Company, which is reflected in its stock price. It is based on ViewRay's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ViewRay's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ViewRay's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.01
Real Value
0.01
Upside
Estimating the potential upside or downside of ViewRay helps investors to forecast how ViewRay stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ViewRay more accurately as focusing exclusively on ViewRay's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details

ViewRay Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining ViewRay's current stock value. Our valuation model uses many indicators to compare ViewRay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ViewRay competition to find correlations between indicators driving ViewRay's intrinsic value. More Info.
ViewRay is rated below average in price to earning category among related companies. It is rated fifth in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value ViewRay by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ViewRay's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ViewRay's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ViewRay's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ViewRay and how it compares across the competition.

About ViewRay Valuation

The delisted stock valuation mechanism determines the current worth of ViewRay on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ViewRay. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ViewRay based exclusively on its fundamental and basic technical indicators. By analyzing ViewRay's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ViewRay's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ViewRay. We calculate exposure to ViewRay's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ViewRay's related companies.
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio. Viewray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 267 people.

8 Steps to conduct ViewRay's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ViewRay's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ViewRay's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain ViewRay's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine ViewRay's revenue streams: Identify ViewRay's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research ViewRay's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish ViewRay's growth potential: Evaluate ViewRay's management, business model, and growth potential.
  • Determine ViewRay's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ViewRay's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

ViewRay Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ViewRay does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding180.7 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the ViewRay information on this page should be used as a complementary analysis to other ViewRay's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in ViewRay Stock

If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data